Investigating Metabolism and Alzheimer’s Disease Through Worm Models
Understanding Alzheimer’s Disease
Alzheimer’s disease is a neurodegenerative disorder marked by memory loss and cognitive decline. This deterioration is primarily attributed to the buildup of protein aggregates known as amyloid-beta (Aβ) peptides, which form insoluble amyloid plaques in the brain. Another hallmark of the disease is the presence of neurofibrillary tangles, resulting from tau proteins that accumulate due to excessive phosphorylation. The precise causes of these protein irregularities remain unclear, although there is growing evidence that alterations in cellular energy metabolism may contribute to neuronal degradation associated with Alzheimer’s.
The Role of Oxidative Stress
Cells generate energy through a process called oxidative phosphorylation, which occurs in the mitochondria and involves glucose and oxygen. This process produces reactive oxygen species (ROS), which can lead to oxidative stress when generated in excess. Oxidative stress damages proteins, lipids, and nucleic acids, contributing to cell dysfunction. Aging cells are particularly vulnerable, experiencing increased oxidative stress that may result in mitochondrial and protein dysfunction. In Alzheimer’s patients, substantial oxidative damage is observed, potentially influencing disease progression. However, the link between oxidative stress and the formation of amyloid plaques and neurofibrillary tangles is not yet fully understood.
Research Study Using Worms to Model Alzheimer’s Disease
Modeling Alzheimer’s Disease with Caenorhabditis elegans
In a recent study published in eLife, researchers from Singapore explored whether metabolic changes in mitochondria play a role in the early stages of Alzheimer’s disease. They utilized Caenorhabditis elegans, a short-lived worm species with a well-mapped genome, making it an ideal model for studying disease progression. The team genetically engineered worms to produce small amounts of human Aβ peptides, leading to observable neuromuscular and behavioral defects that worsen with age. This model allowed researchers to compare the energy metabolism of these transgenic worms to a control group.
Findings on Metabolism and Amino Acids
The study revealed that worms with Alzheimer’s disease displayed lower total levels of amino acids. Further analysis indicated a significant increase in the proportion of amino acids contributing to alpha-Ketoglutarate (aKG). By employing computational analysis and transcriptomics, the researchers mapped metabolic interactions in young worms, identifying critical reactions involving aKG. They discovered a marked reduction in the enzyme activity of aKG dehydrogenase, vital for energy production within the Krebs cycle.
Exploring Oxidative Stress and Mitochondrial Dysfunction
To investigate the effects of aKG dehydrogenase deficiency, the scientists inhibited its production in healthy worms. This resulted in decreased respiration and mirrored the metabolic deficits observed in the Alzheimer’s model. They assessed oxidative stress by measuring protein carbonyl content and found increased carbonylation of mitochondrial proteins in young Alzheimer’s-engineered worms. These findings suggest that oxidative stress within mitochondria may be an early pathogenic event in Alzheimer’s disease.
Potential Therapeutic Implications of Metformin
Effects of Metformin on Worm Models
The researchers also examined the impact of metformin, a drug commonly used to treat diabetes that enhances Krebs cycle metabolism. Treatment with metformin resulted in increased lifespan for worms with Alzheimer’s. To determine the metabolic substrates responsible for this effect, a metabolic analysis was conducted, revealing elevated levels of amino acids involved in the Krebs cycle. Metformin was found to improve energy substrate availability within mitochondria, potentially mitigating Aβ peptide toxicity.
Limitations and Future Directions
While the study supports the notion that metabolic dysfunction precedes amyloid formation in Alzheimer’s progression, several limitations warrant further investigation. The researchers did not establish a definitive mechanism by which metabolic or aKG dysfunction contributes to tau or amyloid plaque formation. They also could not confirm that oxidative stress directly causes Aβ aggregation, only suggesting its role in the early stages of the disease. Although metformin treatment extended the lifespan of the worms, it did not significantly affect Aβ aggregate levels.
Conclusion
This research underscores the complexity of Alzheimer’s disease and highlights the potential of using Caenorhabditis elegans as a model for understanding its metabolic aspects. Further studies are needed to clarify the mechanisms involved and explore therapeutic options that address the metabolic challenges associated with the disease.
References
Huang, W. J., Zhang, X. & Chen, W. W. Role of oxidative stress in Alzheimer’s disease. Biomedical reports 4, 519-522 (2016).
Swerdlow, R. H. Mitochondria and cell bioenergetics: increasingly recognized components and a possible etiologic cause of Alzheimer’s disease. Antioxidants & redox signaling 16, 1434-1455 (2012).
Müller, W. E., Eckert, A., Kurz, C., Eckert, G. P. & Leuner, K. Mitochondrial dysfunction: common final pathway in brain aging and Alzheimer’s disease—therapeutic aspects. Molecular neurobiology 41, 159-171 (2010).
Benedict, C. & Grillo, C. A. Insulin resistance as a therapeutic target in the treatment of Alzheimer’s disease: a state-of-the-art review. Frontiers in neuroscience 12, 215 (2018).
Teo, E. et al. Metabolic stress is a primary pathogenic event in transgenic Caenorhabditis elegans expressing neuronal human amyloid-β. BioRxiv, 708537 (2019).
Image by Tumisu from Pixabay.